Societal challenges of precision medicine: Bringing order to chaos
Roberto Salgado(Institut Jules Bordet), Nils Wilking(Sophiahemmet Hospital), Sumimasa Nagai, Moritz Gerstung(European Bioinformatics Institute), Stephen M. Hewitt(National Institutes of Health), Kathy Oliver(Brain Tumour Charity), Robert Becker(Marywood University), Francesco Pignatti, Augustinus van Dongen, Tracy Lively(National Cancer Institute), Sabine Tejpar(KU Leuven), Tawnya C. McKee(National Cancer Institute), Richard L. Schilsky(American Society of Clinical Oncology), Eric C. Polley(Mayo Clinic in Florida), Thomas Lillie, Daniel O’Connor(Association of the British Pharmaceutical Industry), Mehdi Mesri(National Cancer Institute), Shakun Malik(National Cancer Institute), Philip Beer(Genoscience Pharma (France)), Antonio Tito Fojo, Hartmut Juhl(Dermatologikum Hamburg), Adrian M. Senderowicz, Nitzan Rosenfeld(Queen Mary University of London), Stefan Michiels(Institut Gustave Roussy), Iréne Norstedt, John W.M. Martens(Erasmus MC), Shyamala Maheswaran(Massachusetts General Hospital), Jonas Bergh(Karolinska Institutet), Simon J. Dovedi(Manchester Academic Health Science Centre), Jeffrey A. Moscow(National Cancer Institute), Kim Lyerly Herbert, Jan Bogaerts(European Organisation for Research and Treatment of Cancer), Ultan McDermott(AstraZeneca (United Kingdom)), Olli Tenhunen(University of Oulu), Daniel Hochhauser(Royal London Hospital), Christine Vietz(Boston Foundation), Robert J. Kinders(National Cancer Institute), Helen M. Moore(National Cancer Institute), Denis Lacombe(European Organisation for Research and Treatment of Cancer), Vassilis Golfinopoulos(Champalimaud Foundation), Wim J.G. Oyen(Humanitas University), Erasmus Schneider, Jan H.M. Schellens(Utrecht University)
Cited by 29
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.2k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k